Thanks Christoph.
Some suggestions on the executive summary and a few other small clarificatory questions from me.
Best
Katherine
Von: Npos_2018 [mailto:npos_2018-bounces@testbiotech.de]
Im Auftrag von Matthias Juhas
Gesendet: Montag, 1. März 2021 17:41
An: npos_2018@testbiotech.de
Betreff: Re: [Npos_2018] final draft version of the report ready to go to layout
the executive summary really improves the report.
i wonder, if it's really necessary to delete the column with the names of the companies since this is just "raw data" which is available for everyone who does patent-research. i mean, there's no judgment or the like in it, isnt't it? Or is it also possible
to get SLAPPed for that?
(few minor corrections)
best
matthias
Am 25.02.2021 um 18:56 schrieb Christoph Then: